Comparison of oncologic outcome of preoveratively presumed low-risk endometrial cancer patients who underwent only bilateral pelvic sentinel lymph node (SLN) removal and those who underwent pelvic lymphadenectomy in addition to bilateral pelvic SLN r
SLN mapping, ultrastaging, and immunohistochemical staining can identify low-volume metastases that may not be identified with classic lymphadenectomy and hematoxylin & eosin staining. It has been observed that adding PLA beyond SLN mapping did not provide an additional positive contribution to survival. For endometriod type grade I-II patients, detection of bilateral SLNs in both hemipelvis only, if detectable, is an adequate approach.
Authors
- İlker Kahramanoğlu (ORCID: https://orcid.org/0000-0003-0956-1050)
- Sait Şükrü Çebi (ORCID: https://orcid.org/0000-0002-9152-8227)
- Nedim Tokgözoğlu (ORCID: https://orcid.org/0000-0002-5727-864X)
- Macit Arvas (ORCID: https://orcid.org/0000-0003-2548-1667)
- Tugan Beşe (ORCID: https://orcid.org/0000-0003-4866-1695)
- Mete Güngör (ORCID: https://orcid.org/0000-0001-8010-4181)
- Fırat Ortaç (ORCID: https://orcid.org/0000-0001-6735-5760)
- Salih Taşkın (ORCID: https://orcid.org/0000-0002-9651-2224)
- Hasan Turan (ORCID: https://orcid.org/0000-0003-1902-8014)
- Doğan Vatansever (ORCID: https://orcid.org/0000-0002-7831-7070)
- Cagatay Taskiran (ORCID: https://orcid.org/0009-0009-6568-7679)
- Fuat Demirkıran (ORCID: https://orcid.org/0000-0002-0439-2502)
- Mehmet Faruk Köse (ORCID: https://orcid.org/0000-0001-6136-5597)
Institutions
- Gynecologic Oncology Group (US)
- Koç University (TR)
- Ankara University (TR)
- Istanbul Aydın University (TR)
- Istanbul University-Cerrahpaşa (TR)
- Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi (TR)
- Istanbul Eye Hospital (TR)
- Kent Hastanesi (TR)
Publication Details
- Journal
- Journal of Gynecologic Oncology
- Published
- 2025-10-21
- DOI
- https://doi.org/10.3802/jgo.2026.37.e23
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00